advertisement

---

Hubatsch D 1

Showing records 1 to 1 | Display all abstracts from Hubatsch D

122571 A phase 3 adaptive dose selection trial of NCX 470, a nitric oxide-donating bimatoprost for open-angle glaucoma or ocular hypertension: The MONT BLANC study
Mansberger SL; Fechtner R; Lopez K; Hubatsch D
Contemporary Clinical Trials 2024; 147: 107730

---